Research
A retrospective analysis of the change in anti-malarial treatment policy: Peru
-
* Corresponding author: Holly A Williams hbw2@cdc.gov
1 Malaria Branch, Centers for Disease Control and Prevention (CDC), Mail Stop F-60, 4770 Buford Hwy NE, Atlanta, Georgia 30341, USA
2 Division of Injury Response, CDC, USA
3 Ministerio du Salud, Jesús Maria – Lima, Peru
4 United States Agency for International Development (USAID), Surco, Lima, Peru
5 International Emergency and Refugee Health Branch, Centers for Disease Control and Prevention (CDC), Mail Stop F-60, 4770 Buford Hwy NE, Atlanta, Georgia 30341, USA
Malaria Journal 2009, 8:85 doi:10.1186/1475-2875-8-85
Published: 28 April 2009Additional files
Additional file 1:
Matrix of Stakeholders' Interests, Impact, Influence and Roles. The table describes the affiliations and roles of the major stakeholders, coded to indicate levels of interest, impact and influence.
Format: DOC Size: 55KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Factors Impacting the Process of Changing National Anti-malarial Drug Policy in Peru. Factors that impacted the change in national anti-malarial drug policy are categorized by type and directionality (positive or negative).
Format: DOC Size: 30KB Download file
This file can be viewed with: Microsoft Word Viewer